Inventor · disambiguated record
Akifumi Morinaka
Also filed as: MORINAKA AKIFUMI
8 granted patents·1 pending application·17 citations·filing 2013–2019
81Inventor score
Files withASTELLAS PHARMA INC9
Top patents by PatentIndex Score
9 records- 0191US10517966B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2017·Granted Dec 31, 2019·5 cites·32 claims
- 0289US10507251B2Anti-human MUC1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Dec 17, 2019·3 cites·17 claims
- 0387US11679166B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Jun 20, 2023·2 cites·21 claims
- 0480US9481911B2Methods for detecting FGFR3/TACC3 fusion genesASTELLAS PHARMA INC·Filed 2013·Granted Nov 1, 2016·6 cites·12 claims
- 0567US10316086B2Anti-human Igβ antibodyASTELLAS PHARMA INC·Filed 2015·Granted Jun 11, 2019·1 cites·10 claims
- 0667US2020171174A1Novel anti-human muc1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Application pending·0 cites
- 0760US11059889B2Anti-human Igβ antibodyASTELLAS PHARMA INC·Filed 2019·Granted Jul 13, 2021·0 cites·2 claims
- 0847US10004739B2Methods for treating cancer by inhibiting FGFR3/TACC3 fusion proteinASTELLAS PHARMA INC·Filed 2016·Granted Jun 26, 2018·0 cites·10 claims
- 0946US12202908B2Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligandASTELLAS PHARMA INC·Filed 2019·Granted Jan 21, 2025·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Akifumi Morinaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →